Cytokeratin 20 (CK20) and cytokeratin 7 (CK7) immunohistochemistry was used to validate the utility of the TMA, and the expression of these proteins was ...Clipboard,SearchHistory,andseveralotheradvancedfeaturesaretemporarilyunavailable.SkiptomainpagecontentCOVID-19InformationPublichealthinformation(CDC)Researchinformation(NIH)SARS-CoV-2data(NCBI)Preventionandtreatmentinformation(HHS)Español AccesskeysNCBIHomepageMyNCBIHomepageMainContentMainNavigationSearch:SearchAdvancedClipboardUserGuideSaveEmailSendtoClipboardMyBibliographyCollectionsCitationmanagerDisplayoptionsDisplayoptionsFormatAbstractPubMedPMIDSavecitationtofileFormat:Summary(text)PubMedPMIDAbstract(text)CSVCreatefileCancelEmailcitationSubject:1selecteditem:15791572-PubMedTo:Format:SummarySummary(text)AbstractAbstract(text)MeSHandotherdataSendemailCancelAddtoCollectionsCreateanewcollectionAddtoanexistingcollectionNameyourcollection:Namemustbelessthan100charactersChooseacollection:UnabletoloadyourcollectionduetoanerrorPleasetryagainAddCancelAddtoMyBibliographyMyBibliographyUnabletoloadyourdelegatesduetoanerrorPleasetryagainAddCancelYoursavedsearchNameofsavedsearch:Searchterms:TestsearchtermsWouldyoulikeemailupdatesofnewsearchresults?SavedSearchAlertRadioButtonsYesNoEmail:(change)Frequency:MonthlyWeeklyDailyWhichday?ThefirstSundayThefirstMondayThefirstTuesdayThefirstWednesdayThefirstThursdayThefirstFridayThefirstSaturdayThefirstdayThefirstweekdayWhichday?SundayMondayTuesdayWednesdayThursdayFridaySaturdayReportformat:SummarySummary(text)AbstractAbstract(text)PubMedSendatmost:1item5items10items20items50items100items200itemsSendevenwhentherearen'tanynewresultsOptionaltextinemail:SaveCancelCreateafileforexternalcitationmanagementsoftwareCreatefileCancelYourRSSFeedNameofRSSFeed:Numberofitemsdisplayed:510152050100CreateRSSCancelRSSLinkCopyFulltextlinksElsevierScienceFulltextlinksActionsCiteFavoritesDisplayoptionsDisplayoptionsFormatAbstractPubMedPMIDSharePermalinkCopyPagenavigationTitle&authorsAbstractCommentinSim

In addition to CK7 and CK20 cytokeratins, some of the markers often used routinely are more specific for the primary site. No single antibody is ...NCBISkiptomaincontentSkiptonavigationResourcesHowToAboutNCBIAccesskeysMyNCBISignintoNCBISignOutJournalListCancers(Basel)v.10(4);2018AprPMC5923363Cancers(Basel).2018Apr;10(4):108.Publishedonline2018Apr5.doi: 10.3390/cancers10040108PMCID:PMC5923363PMID:29621151ImmunohistochemistryforDiagnosisofMetastaticCarcinomasofUnknownPrimarySiteJanickSelves,1ElodieLong-Mira,2Marie-ChristineMathieu,3PhilippeRochaix,1andMariusIlié2,*JanickSelves1DépartementD’anatomieetCytologiePathologiques,InstitutUniversitaireduCancer-Oncopole,1AvenueIrèneJoliot-Curie,31059ToulouseCEDEX9,France;[email protected](J.S.);[email protected](P.R.)FindarticlesbyJanickSelvesElodieLong-Mira2LaboratoiredePathologieCliniqueetExpérimentale,HôpitalPasteur,FHUOncoage,UniversitéCôted’Azur,30VoieRomaine,06000Nice,France;rf.ecin-uhc@e.arim-gnolFindarticlesbyElodieLong-MiraMarie-ChristineMathieu3DépartementdeBiologieetPathologieMédicales,InstitutGustaveRoussy,114,rueEdouardVaillant,94805Villejuif,France;rf.yssuorevatsug@UEIHTAM.enitsirhC-eiraMFindarticlesbyMarie-ChristineMathieuPhilippeRochaix1DépartementD’anatomieetCytologiePathologiques,InstitutUniversitaireduCancer-Oncopole,1AvenueIrèneJoliot-Curie,31059ToulouseCEDEX9,France;[email protected](J.S.);[email protected](P.R.)FindarticlesbyPhilippeRochaixMariusIlié2LaboratoiredePathologieCliniqueetExpérimentale,HôpitalPasteur,FHUOncoage,UniversitéCôted’Azur,30VoieRomaine,06000Nice,France;[email protected]éAuthorinformationArticlenotesCopyrightandLicenseinformationDisclaimer1DépartementD’anatomieetCytologiePathologiques,InstitutUniversitaireduCancer-Oncopole,1AvenueIrèneJoliot-Curie,31059ToulouseCEDEX9,France;[email protected](J.S.);[email protected](P.R.)2LaboratoiredePathologieCliniqueetExpérimentale,HôpitalPasteur,FHUOncoa

Stains & molecular markers - Cytokeratin 7 (CK7, K7) ... CK7 / CK20 profiles (general patterns, specificity varies): CK7+ / CK20+: Extrahepatic ...AuthorsBlogBoardReviewCommentContactUsNewslettersStatisticsTestimonialsSeeElsevier'snewvideoabouttheirClinicReviewArticlesonourhomepageorclickhere.JobsFellowshipsConferences/WebinarsBooksCMECasesAdvertiseGrantsMedicalNewsLibrariesRocheCompanionDiagnosticLibraryRocheNTRKIHCDiagnosticLibraryCOVID-19LibraryPandemicreliefmusicawardHome>Stains&molecularmarkers>Cytokeratin7(CK7,K7)Stains&molecularmarkersCytokeratin7(CK7,K7)Authors: KrutiP.Maniar,M.D.,BrandonUmphress,M.D.EditorialBoardMembers: MariaTretiakova,M.D.,Ph.D.,RaulS.Gonzalez,M.D.Editor-in-Chief: DebraL.Zynger,M.D.TopicCompleted:17September2020Minorchanges:10February2021Copyright:2003-2021,PathologyOutlines.com,Inc.PubMedSearch:CK7stain"loattrfreefulltext"[sb]Pageviewsin2020:65,817Pageviewsin2021todate:22,446TableofContentsDefinition/general|Essentialfeatures|Terminology|Pathophysiology|Usesbypathologists|Prognosticfactors|Interpretation|Microscopic(histologic)images|Positivestaining-normal|Positivestaining-notmalignant|Positivestaining-malignant|Negativestaining-normal|Negativestaining-tumor/disease|Samplepathologyreport|Boardreviewstylequestion#1|Boardreviewstyleanswer#1|Boardreviewstylequestion#2|Boardreviewstyleanswer#2|Boardreviewstylequestion#3|Boardreviewstyleanswer#3Citethispage:ManiarKP,UmphressB.Cytokeratin7(CK7,K7).PathologyOutlines.comwebsite.https://www.pathologyoutlines.com/topic/stainsck7.html.AccessedApril21st,2021.Definition/generalTypeIIkeratinofsimplenonkeratinizingepithelia;molecularweight51.4kDa(OMIM:Keratin7,TYPEII;KRT7[Accessed14September2020])Expressionsimilartobutmorelimitedthankeratins8and18insimple,pseudostratifiedandductalepithelium,mesotheliumandurotheliumEssentialfeaturesMembranous/cytoplasmicmarkerwithexpressioninmanynormalepitheliaandepithelialtumorsDespitewidedistribution,usefulaspartofapanelindeterminingprimarysiteofmetastaticcarcinomaG

Objective: To study the expression of CK7/CK20 in intrahepatic cholangiocarcinoma and hepatolithiasis. Methods: CK7/CK20 were analysed in 30 cases of ...隨時查．隨時看，你的隨身圖書館已上線!立即使用DOI是數位物件識別碼（DigitalObjectIdentifier）的簡稱，為物件在網路上的唯一識別碼，可用於永久連結並引用目標物件。

使用DOI作為永久連結每個DOI號前面加上「http://dx.doi.org/」便成為永久網址。

如以DOI號為10.5297/ser.1201.002的文獻為例，此文獻的永久連結便是：http://dx.doi.org/10.5297/ser.1201.002。

日後不論出版單位如何更動此文獻位置，永久連結所指向的位置皆會即時更新，不再錯失重要的研究。

引用含有DOI的文獻有DOI的文獻在引用時皆應同時引用DOI。

若使用APA、Chicago以外未規範DOI的引用格式，可引用DOI永久連結。

DOI可強化引用精確性、增強學術圈連結，並給予使用者跨平台的良好使用經驗，目前在全世界已有超過五千萬個物件申請DOI。

如想對DOI的使用與概念有進一步了解，請參考華藝DOI註冊中心（doi.airiti.com）。

ACI:數據來源：AcademicCitationIndex，簡稱ACI臺灣地區最大的引用文獻資料庫，目前收錄臺灣地區所出版的人文學、社會學領域學術期刊，穩定出刊中的期刊總量約400種，若包含已收錄但後續停刊的期刊，總期刊量超過500種，每年定期公布收錄期刊的影響係數(ImpactFactor)等指標給大眾，並可提供專家學者免費進行學術研究使用。

影響指數（ImpactFactor）：某一期刊前兩年產出的論文，在統計年平均被引用的次數。

公式：（前兩年發表論文在統計年的被引用次數）÷（前兩年論文產出論文總篇數）例如：2010年之影響係數（2011年呈現）2009年A期刊產出論文15篇，2009年A期刊產出論文在2009年被引用20次2008年A期刊產出論文16篇，2008年A期刊產出論文在2009年被引用30次→2010年的影響係數=（20+30）÷（15+16）≒1.61什麼是預刊文章？為提供讀者最前線之學術資訊，於期刊文獻獲同意刊登後、紙本印製完成前，率先於網路線上發表之文章即為預刊文章。

預刊文章尚未有卷期、頁次及出版日期資訊，但可藉由DOI號識別。

DOI號是文獻的數位身份證字號，不論預刊或正式出版皆不會改變，讀者可點擊DOI連結，或於DOI號前面加上「http://dx.doi.org/」連結到文獻目前最新版本。

如何引用預刊文章？請使用預刊文章的線上發表日期及DOI號來引用該篇文獻。

引用範例(視不同引文格式規範可能有所差異)：作者姓名。

文章篇名。

期刊名稱。

YYYY/MM/DD線上預先發表。

doi:DOI號來源資料中國現代普通外科進展13卷5期(2010/05/30)创伤性休克137例临床救治分析快速康复外科在26例阑尾炎穿孔患者中的应用胃上部癌根治术中保留脾脏与复发及转移和预后的相关性研究CK7和CK20在肝内胆管癌及肝内胆管结石旁胆管组织中的表达胰腺实性假乳头状肿瘤的诊断与治疗胃肠道间质瘤治疗方式选择与分析缺血后处理对骨骼肌缺血再灌注后肺损伤保护作用的机制腹腔镜辅助胃癌根治术16例分析腹腔置管灌洗治疗重症急性胰腺炎并发腹腔间隔室综合征Ⅰ期低位直肠癌经肛门局部切除29例P373-375+404醫藥衛生>外科訂閱目次書目管理工具書目匯出加入收藏加入購物車E-mail給朋友列印書目相關連結問題回報購買單篇全文下載CK7和CK20在肝内胆管癌及肝内胆管结石旁胆管组织中的表达ExpressionofCK7/CK20inIntrahepaticCholagiocarcinomaandHepatolithiasis王猛(MengWang)；赵勇(YongZhao)；孙国志(Guo-ZhiSun)；王思暖(Si-NuanWang)中國現代普通外科進展；13卷5期(2010/05/30)，P373-375+404簡體中文胆管肿瘤；肝内胆管结石；细胞角蛋白；Intrahepaticcholangiocarcinoma；Hepatolithiasis；Cytokeratin分享到摘要│文

CK7 / CK20 Carcinoma Antibody Duo contains anti-Cytokeratin 7 antibody [SQab1888],anti-Cytokeratin 20 antibody [SQab1737]TogglenavigationSearchProductAntibodiesPrimaryAntibodiesSecondaryAntibodiesAntibodyDuosELISAKitsScienceOurApproachandGuaranteeLibrarySpecialtyProductHighlightarigominifilmGainDataSupportOrderingInquiryFAQProtocolandTipsRewardProgramPromotionCompanyAboutarigoContactUsDistributorsNewsHomeProductsAntibodyDuosandPanelsCK7/CK20CarcinomaAntibodyDuoARG30318CK7/CK20CarcinomaAntibodyDuoDatasheetOrderingInformationPackagePrice1pairInternationalcustomerspleasecontactyourlocal distributor or [email protected] toplaceanorder.DatasheetComponentCatNoComponentNameHostclonalityReactivityApplicationPackageARG66340anti-Cytokeratin7antibody[SQab1888]RabbitmAbHu,MsFACS,ICC/IF,IHC-P,IP,WB50μlARG66248anti-Cytokeratin20antibody[SQab1737]RabbitmAbHuFACS,ICC/IF,IHC-P,IP,WB50μlOverviewProductDescriptionCK7andCK20arethetwomostcommoncytokeratinsusedforidentifyingprimarytumorsites.Forexample,CK7+/CK20+isassociatedwithcarcinomaoftransitionalcellorovarianorigin;CK7+/CK20−isseeninmanycarcinomasincludingthoseofthelung,breast,thyroid,andfemalegenitaltract;CK7−/CK20+isthehallmarkofcolorectalcarcinomaandmerkelcellcarcinoma;andCK7−/CK20−isshownincarcinomafromprostate,hepatocellular,renal,orsquamouscellorigin.arigo'sCK7/CK20CarcinomaAntibodyDuocomprisesCK5andCK20antibodies.BotharerabbitmonoclonalantibodieswithexcellentperformanceonIHCandotherapplication.Thisantibodypanelisanexcellentsolutionforidentifyingprimarytumororigininmetastaticcancertissues.TargetNameCK7/CK20CarcinomaFullNameCytokeratin7(CK7)/Cytokeratin20(CK20)CarcinomaAntibodyDuoAlternateNamesCK7/CK20Carcinomaantibody;Cytokeratin7/Cytokeratin20Carcinomaantibody;Cytokeratin20antibody;Cytokeratin7antibodyPropertiesNoteForlaboratoryresearchonly,notfordrug,diagnosticorotheruse.Images(11)ClickthePicturetoZoomInARG66340anti-Cytokeratin7antibody[SQab1888]IHC-PimageImmunohistochemistry:10%Formalin-fixedandparaffin-embeddedMousetumor